![](/img/cover-not-exists.png)
Hormone-receptor status and likelihood of predicting pathological complete response (pCR) in the NOAH trial of neoadjuvant trastuzumab in patients (pts) with HER2-positive locally advanced breast cancer (LABC)
W. Eiermann, J. Baselga, V. Semiglazov, M. Byakhov, E. Ciruelos, B. Ojeda, A. Feyereislova, M. Zambetti, P. Valagussa, L. GianniVolume:
6
Year:
2008
Language:
english
DOI:
10.1016/s1359-6349(08)70544-5
File:
PDF, 63 KB
english, 2008